Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 1276 to 1290 of 1834 results for carers

  1. Managing delirium superimposed on dementia:- What are the most clinically and cost-effective non-pharmacological interventions for helping the long-term recovery of people with delirium superimposed on dementia?

    assessment, management and support for people living with dementia and their carers Number NG97 Date issued June 2018 Other details

  2. Pegcetacoplan for treating geographic atrophy [ID4041]

    In development Reference number: GID-TA11351 Expected publication date: TBC

  3. The NICE public health guidance development process (third edition) (PMG5)

    This manual describes how public health guidance is produced, and explains the stages of guidance development, the different activities, roles and responsibilities of different groups of people involved at different stages

  4. Evidence summaries: unlicensed and off-label medicines – Interim process statement (PMG2)

    This interim process statement sets out to guide the development of 'Evidence summaries: unlicensed and off-label medicines' (ESUOMs). It provides an overview of the key process principles and describes all stages of development for ESUOMs

  5. Safety and safeguarding:- What safeguarding practices are most effective in improving outcomes for people using services?

    safeguarding in maintaining safety and wellbeing of service users and their carers. Analysis of routine monitoring data, for example...

  6. Past research and projects

    NICE's past research and projects

  7. What information and support do people with diverticulosis, diverticular disease or acute diverticulitis need?

    diverticulosis, diverticular disease and diverticulitis and their families and carers. The evidence was from a symptom-based...

  8. Recommendation 3 Barriers and facilitators. Who should take action? Research councils, commissioners and funders. Researchers and investigators.

    aspects - socioeconomic group - gender (boys in particular) - age Ask parents, carers and families of children younger than 6 what...

  9. Molnupiravir for treating COVID-19 (TA1056)

    Evidence-based recommendations on molnupiravir (Lagevrio) for treating mild to moderate COVID-19 in adults who have a positive SARS-CoV-2 test.

  10. Support for black and minority ethnic groups:- How effective and cost effective are different approaches to supporting people from black and minority ethnic groups using intermediate care?

    experiences of people from black and minority ethnic groups, their family, carers, practitioners and voluntary support groups to inform...

  11. Models of supported living:- What is the effectiveness and cost effectiveness of models of shared, supported living, such as Shared Lives?What are the views and experiences of people sharing their home and people who live with themunder programmes such as Shared Lives?

    learning disability and behaviour that challenges and their families and carers, as well as for Shared Lives families. Source guidance...

  12. Developing a 'risk positive' approach in care homes:- What is the effectiveness and acceptability of different strategies to enable positive risk-taking in care homes?

    homes- the views and experiences of people using care home services and their carers- barriers and facilitators to risk-positive...

  13. Guide to the technology appraisal and highly specialised technologies appeal process (PMG41)

    This guide outlines the appeal process for the technology appraisal and highly specialised technologies guidance. It sets out the process that NICE follows for appeals and provides guidance for those who wish to make an appeal or who are considering doing so